The Full Federal Court has dismissed the Commonwealth s appeal, and confirmed the dismissal of the Commonwealth s $325 million damages claim against Sanofi, for PBS cost-savings it says it would have made, but for a preliminary injunction that prevented generic pharmaceutical company, Apotex, from launching its own clopidogrel products.